Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 3
2003 1
2004 1
2005 2
2006 2
2008 1
2009 1
2010 3
2011 4
2012 4
2013 13
2014 8
2015 7
2016 11
2017 14
2018 11
2019 15
2020 20
2021 12
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 32859703

108 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy.
Krebs S, O'Donoghue JA, Biegel E, Beattie BJ, Reidy D, Lyashchenko SK, Lewis JS, Bodei L, Weber WA, Pandit-Taskar N. Krebs S, et al. Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3047-3057. doi: 10.1007/s00259-020-04832-9. Epub 2020 May 6. Eur J Nucl Med Mol Imaging. 2020. PMID: 32378020 Clinical Trial.
Clinical Assessment of 177Lu-DOTATATE Quantification by Comparison of SUV-Based Parameters Measured on Both Post-PRRT SPECT/CT and 68Ga-DOTATOC PET/CT in Patients With Neuroendocrine Tumors: A Feasibility Study.
Thuillier P, Maajem M, Schick U, Blanc-Beguin F, Hennebicq S, Metges JP, Salaun PY, Kerlan V, Bourhis D, Abgral R. Thuillier P, et al. Clin Nucl Med. 2021 Feb 1;46(2):111-118. doi: 10.1097/RLU.0000000000003412. Clin Nucl Med. 2021. PMID: 33234927
108 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page